| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.045 | 22.099 | 32.589 | 20.150 | 19.759 | 30.534 | 22.086 | 28.102 | 16.789 | 21.365 |
| Total Income - EUR | 24.045 | 22.099 | 32.589 | 21.225 | 20.738 | 31.123 | 22.086 | 28.102 | 16.789 | 21.365 |
| Total Expenses - EUR | 5.029 | 4.607 | 11.888 | 9.724 | 7.770 | 15.614 | 14.003 | 30.589 | 24.054 | 11.873 |
| Gross Profit/Loss - EUR | 19.016 | 17.492 | 20.701 | 11.501 | 12.969 | 15.509 | 8.083 | -2.487 | -7.266 | 9.492 |
| Net Profit/Loss - EUR | 18.294 | 16.829 | 19.515 | 10.865 | 12.376 | 14.917 | 7.420 | -3.330 | -7.266 | 7.863 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cipromed Ddd S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 337 | 134 | 0 | 0 | 980 | 2.327 | 37.734 | 17.071 | 1.356 | 1.961 |
| Current Assets | 40.319 | 56.922 | 59.040 | 65.463 | 73.728 | 87.579 | 10.786 | 4.114 | 1.669 | 6.077 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.181 | 1.019 | 2.059 | 663 | 455 | 660 | 1.364 | 2.398 | 454 | 391 |
| Cash | 38.138 | 55.903 | 56.980 | 64.800 | 73.274 | 86.919 | 9.422 | 1.716 | 1.216 | 5.686 |
| Shareholders Funds | 40.606 | 57.021 | 48.208 | 58.188 | 69.437 | 83.038 | 29.993 | -4.870 | -12.121 | -4.190 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50 | 35 | 10.832 | 7.276 | 5.271 | 6.868 | 18.528 | 26.055 | 15.146 | 12.228 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Cipromed Ddd S.r.l.